Partnering with a reliable CDMO is vital to ensure your drug product needs are met. With a substantial track record in transferring diverse and innovative biological formats, Lonza earns the trust of biotechnology and pharmaceutical companies at every stage.
We can help de-risk with a seamless technology transfer by offering:
Access to state-of-the-art lines (isolator technology, Annex-1 compliant), supported by a network of technical experts
Clinical and Commercial vial (liquid/lyo) or prefilled syringe (PFS) filling solutions
A partner with an industry-leading track record of successfully facilitating>50 new product introductions in the last 12 months